TITLE

tacalcitol

PUB. DATE
January 2002
SOURCE
Royal Society of Medicine: Medicines;2002, p522
SOURCE TYPE
Book
DOC. TYPE
Reference Entry
ABSTRACT
The article presents information on tacalcitol which is an analogue of vitamin D. This drug is used as a skin treatment for plaque psoriasis. Administration is topical. There may be local irritation including itching, burning, erythema and tingling in the extremities. It should not be used in patients with disorders of calcium metabolism. Administer with care to those who are pregnant. Avoid the scalp or contact with eyes and body areas not being treated.
ACCESSION #
18961754

 

Related Articles

  • tazarotene.  // Royal Society of Medicine: Medicines;2002, p523 

    The article presents information on tazarotene which is chemically a derivative of retinol or vitamin A. This drug can be used to treat mild to moderate plaque psoriasis. Administration is by topical application. It should not be used in pregnancy or breast-feeding. Patients should wash hands...

  • Treating Itch in Psoriasis. Dawn, Aerlyn; Yosipovitch, Gil // Dermatology Nursing;Jun2006, Vol. 18 Issue 3, p227 

    The article presents a study on the effective management and treatment of psoriatic itch. Patients with chronic pruritus often have difficulty sleeping, problems concentrating, lowered sex drive, and depression. The treatments recommended for psoriatic itch are tar products, topical...

  • Offer systemic therapy as first-line defense. Rutledge, Barbara J. // Dermatology Times;Sep2005 Supplement 4, Vol. 25, pS16 

    Evaluates the efficacy of alefacept therapy as first-line defense for psoriasis. Impact of psoriasis on the quality of life of the patient; Number of people affected with the disease of the year; Treatment paradigms for psoriasis.

  • Curatoderm.  // Royal Society of Medicine: Medicines;2002, p177 

    This article presents information on curatoderm. This drug is a proprietary, prescription-only preparation of derivative tacalcitol, a vitamin D analogue which can be used as a skin treatment for plaque psoriasis. It is available as an ointment.

  • Topical Vitamin D Analogs. Kieffer, Michael A. // Dermatology Nursing;Feb2004, Vol. 16 Issue 1, p89 

    Presents information on calcipotriene, a synthetic analog of vitamin D3 which is a safe and effective option in the treatment of plaque psoriasis. Explanation that vitamin D plays a critical role in maintaining adequate levels of serum calcium and phosphorous that are both essential for...

  • New oral psoriasis agents show promise. Jesitus, John // Dermatology Times;Sep2004 Supplement, Vol. 25, pS13 

    Introduces different oral treatment for psoriasis. Side effects of the retinoid, an oral tazarotene; Acquisition of a new oral formulation of the drug BG-12 oral fumarate by Biogen; Discussion on the effects of oral pimecrolimus on psoriatic patients.

  • Biologies for psoriasis pulling their weight. Wilson, Fred // Dermatology Times;Sep2004 Supplement, Vol. 25, pS18 

    The article discusses the effect of biologic therapy on psoriatic patients. Consideration of Amevive as the first biologic drug approved for moderate to severe plaque psoriasis; Elaboration on the effects of the drug, Raptiva; Responses of patients to Remicade infusions.

  • Easing trepidation about biologies. Kapes, Beth // Dermatology Times;Sep2004 Supplement, Vol. 25, pS27 

    Discusses the benefits offered by biologics for psoriasis treatment. Affirmation of David E. Cohen that the new biologic products offer advantages over existing medications; Presentation of new biologics that are approved for treating moderate to sever psoriasis and psoriatic arthritis;...

  • Physician says TNF-a antagonists very safe, overall. Guttman, Cheryl // Dermatology Times;Sep2004 Supplement, Vol. 25, pS33 

    Reports that TNF-a antagonists are safe for psoriatic patients. Presentation of several antagonists safe for psoriatic therapy; Discussion on the risks of serious infections and malignancies related to the immunosuppressive activity of the TNF-a antagonist; Effects on patients after treated with...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics